Loading
Latest filing published 20 Apr 2026 for 티앤알바이오팹, €38k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
심주성 (senior executive) discloses dealings in 티앤알바이오팹 to DART (FSS). In total, 3 filings cover trades dated from 19 September 2025 to 14 April 2026.
The open-market record is one-sided, with 2 purchases worth €38k and not one sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 2 purchases and no sales.
Most recently, on 20 April 2026, the filings show an open-market purchase worth €38k in 티앤알바이오팹. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.